Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection

被引:58
作者
Rose, AG
Cooper, DKC
机构
[1] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[2] Fairview Univ, Med Ctr, Minneapolis, MN USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA USA
关键词
allograft; antibody-mediated rejection; cardiac xenograft; hyperacute rejection; venous thrombosis; venular endothelial mediators of inflammation;
D O I
10.1034/j.1399-3089.2000.00042.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A review of the histopathologic features of serial biopsies and excised grafts of 117 experimental and clinical cardiac allografts and xenografts revealed a common sequence in the development of histopathologic changes in grafts showing antibody-mediated (hyperacute and acute vascular) rejection. Based on these observations, we propose the new concept that thrombosis of cardiac veins and venules is the initial key event in antibody-mediated rejection. This is followed by the development of congestion in the subtended venules and capillaries accompanied by interfascicular and, later, intermyocyte edema. Subsequently, focal or diffuse interstitial hemorrhage affecting the subendocardium, extending sometimes to involve the inner half of the ventricular myocardium, is observed. Antibody-mediated rejection therefore appears to be analogous to incomplete venous infarction of the heart. The observed histopathology (in which venular thrombosis plays a key role) favors a thrombogenic basis for the classical features of antibody-mediated rejection, namely edema, vascular thrombi and interstitial hemorrhage. A key role for venular thrombosis would explain the non-uniform distribution of the changes and may suggest new ways of preventing antibody-mediated xenograft rejection.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 36 条
[1]  
BARNARD CN, 1977, S AFR MED J, V52, P1035
[2]  
BILLINGHAM ME, 1992, HISTOLOGY PATHOLOGIS, P215
[3]   IMMUNOSUPPRESSIVE EFFECTS OF SOLUBLE CELL MEMBRANE FRACTIONS, DONOR BLOOD AND SERUM ON RENAL ALLOGRAFT SURVIVAL [J].
CALNE, RY ;
DAVIS, DR ;
HADJIYANNAKIS, E ;
SELLS, RA ;
WHITE, D ;
HERBERTSON, BM ;
MILLARD, PR ;
JOYSEY, VC ;
DAVIES, DAL ;
BINNS, RM ;
FESTENSTEIN, H .
NATURE, 1970, 227 (5261) :903-+
[4]   HYPERACUTE REJECTION OF GUINEA-PIG TO RAT CARDIAC XENOGRAFTS .1. MORPHOLOGY [J].
CATTELL, V ;
JAMIESON, SW .
JOURNAL OF PATHOLOGY, 1975, 115 (03) :183-&
[5]   Differential galactose α(1,3) galactose expression by porcine cardiac vascular endothelium [J].
Chen, RH ;
Mitchell, RN ;
Kadner, A ;
Adams, DH .
XENOTRANSPLANTATION, 1999, 6 (03) :169-172
[6]  
Cooper DK, 1996, XENOTRANSPLANTATION, V4, P27
[7]  
COOPER DKC, 1989, J THORAC CARDIOV SUR, V97, P447
[8]   SPECIFIC INTRAVENOUS CARBOHYDRATE THERAPY - A NEW CONCEPT IN INHIBITING ANTIBODY-MEDIATED REJECTION EXPERIENCE WITH ABO-INCOMPATIBLE CARDIAC ALLOGRAFTING IN THE BABOON [J].
COOPER, DKC ;
YE, Y ;
NIEKRASZ, M ;
KEHOE, M ;
MARTIN, M ;
NEETHLING, FA ;
KOSANKE, S ;
DEBAULT, LE ;
WORSLEY, G ;
ZUHDI, N ;
ORIOL, R ;
ROMANO, E .
TRANSPLANTATION, 1993, 56 (04) :769-777
[9]  
COOPER DKC, 1988, J HEART TRANSPLANT, V7, P238
[10]  
COOPER DKC, 1990, TRANSPLANT P, V22, P1966